98%
921
2 minutes
20
Purpose: To assess the usefulness of and predictive factors for pleurodesis using 50% glucose solution to treat air leak after pulmonary resection.
Methods: The subjects of this retrospective study were 70 patients from three Japanese institutions, who were treated with 50% glucose solution for postoperative air leak between April, 2015 and March, 2023. Air leak was monitored using a digital drainage system. We analyzed the patient characteristics, surgical details, and outcomes. Successful pleurodesis was defined as control of the air leak within two attempts and no recurrence within 1 month after drain removal. Predictors of success were identified using multivariable logistic regression.
Results: Pleurodesis with 50% glucose solution treated air leak successfully in 58 patients (83%), with a median time from resection to pleurodesis of 4 days. Air leak control was achieved within 2 days in 93% of these patients. Air leak volume < 300 mL/min before pleurodesis and an air space rate < 10% calculated on chest radiograph were independent predictors of success. The success rate for patients with both or none of these factors was 97% and 29%, respectively. No life-threatening complications were observed.
Conclusions: Pleurodesis using 50% glucose solution could be useful for managing postoperative air leak, especially in patients with an air leak volume < 300 mL/min and an air space rate < 10%.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00595-025-03041-x | DOI Listing |
Ann Afr Med
September 2025
Department of Orthopaedics, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India.
Introduction: Pediatric endotracheal intubation is challenging due to airway anatomical differences. Accurate endotracheal tube (ETT) sizing is crucial for effective ventilation and preventing complications. Traditional age, weight, or height-based methods are often unreliable, leading to multiple attempts.
View Article and Find Full Text PDFPediatr Pulmonol
September 2025
Department of Neonatology, Lady Hardinge Medical College and Associated Hospitals, New Delhi, India.
Background: Meconium aspiration syndrome (MAS), a common cause of respiratory failure in late preterm and term neonates, is associated with a high risk of mortality and morbidity. Amongst all the treatment modalities for severe MAS, surfactant administration has a proven role in decreasing progressive respiratory failure.
Methods: The present open-label randomised controlled trial aimed to determine the effect of early (≤ 2 h) bolus surfactant therapy as compared to standard care on the total duration of respiratory support.
JTCVS Open
August 2025
Department of Surgery, University at Buffalo, Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY.
Objective: Persistent pulmonary air leak happens in a minority of patients with various thoracic pathologies. Spiration (Olympus America Inc.) bronchial valves (BVs) are approved by the Food and Drug Administration under Humanitarian Use Device status to treat persistent air leak after lung resection.
View Article and Find Full Text PDFCureus
August 2025
Respiratory Medicine, Dartford and Gravesham NHS Trust, Dartford, GBR.
Pressure-dependent pneumothorax is an under-recognized but clinically significant phenomenon that complicates pleural fluid drainage, particularly in patients with non-expandable lungs due to malignancy or chronic pleural fibrosis. Unlike pressure-independent pneumothorax, this condition arises from the pronounced transpleural pressure gradient generated during therapeutic thoracentesis or chest drainage. This negative pressure transiently distorts the visceral pleura, allowing air to enter the pleural space until an equilibrium is reached.
View Article and Find Full Text PDFPeerJ
September 2025
Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Background: This meta-analysis aimed to evaluate differences in perioperative outcomes and costs between robotic-assisted partial pulmonary resection (RAPPR) and video-assisted thoracoscopic partial pulmonary resection (VATPPR).
Methods: We systematically searched MEDLINE, PubMed, Google Scholar, and Cochrane databases for relevant studies published between March 2015 and March 2025. Propensity score-matched non-randomized controlled studies comparing RAPPR with VATPPR were included.